Hepatoprotection of Paederia scandens (Lour.) Merr. on Acetaminophen-Related Hepatic Injury Rats by 1H-NMR-Based Metabonomics Coupled with Network Pharmacology

Chao-Ling Tang; Ning Ma; Wan-Ying Sun; Wei Wang; Li-Peng Zhu; Rui-Qi Wang; Jie-Yan Liu; Xiao-Po Zhang

doi:10.1155/2022/1375864

Hepatoprotection of Paederia scandens (Lour.) Merr. on Acetaminophen-Related Hepatic Injury Rats by ¹H-NMR-Based Metabonomics Coupled with Network Pharmacology

Evid Based Complement Alternat Med. 2022 Aug 22:2022:1375864. doi: 10.1155/2022/1375864. eCollection 2022.

Authors

Chao-Ling Tang¹, Ning Ma², Wan-Ying Sun³, Wei Wang¹, Li-Peng Zhu¹, Rui-Qi Wang³, Jie-Yan Liu⁴, Xiao-Po Zhang³

Affiliations

¹ Department of Pharmacy, The First Affiliated Hospital of Hainan Medical University, Haikou 571000, China.
² Reproductive Medicine Center, Women and Children Medical Center of Hainan Province, Haikou 571000, China.
³ Key Laboratory of Tropical Translational Medicine of Ministry of Education, Hainan Key Laboratory for Research and Development of Tropical Herbs, School of Pharmacy, Hainan Medical University, Haikou 571199, China.
⁴ Department of Pharmacy, Yongzhou Central Hospital, Yongzhou 425000, China.

Abstract

Background: Acetaminophen-related hepatic injury (ARHI) is a kind of acute hepatic injury caused by overdosing acetaminophen, which is mainly related to toxic metabolite production, oxidative stress, and mitochondrial dysfunction. The extract of Paederia scandens (Lour.) Merr. (PSM) has the abilities of anti-inflammatory, antivirus, and antioxidation. Research studies showed that PSM could improve acute or chronic hepatic injury, while the mechanism of which is still indistinct.

Methods: Here, the authors applied the approach based on serum metabonomics combined with network pharmacology to study the protection of PSM on ARHI rats.

Results: 10 serum potential biomarkers were found to be closely related to ARHI by metabonomics, while 3 compounds (L-ascorbyl 2,6-dipalmitate, squalene, and tributyl O-acetylcitrate) and 3 targets (NOS2, MAOB, and PDE3A) were found that might be the potential active components and active site of PSM on treating ARHI by network pharmacology analysis. Furthermore, molecular biology strategy was performed to validate whether iNOS/NF-κB signaling pathway is the potential mechanism of PSM treating ARHI.

Conclusions: This study indicated that PSM could ameliorate ARHI by iNOS/NF-κB signaling pathway. During ARHI treatment by PSM, L-ascorbyl 2, 6-dipalmitate, squalene, and tributyl O-acetylcitrate might be the potential active components, while the possible active site might be NOS2, MAOB, and PDE3A.